	Recent advances in 1,3,5-triazine-based PI3K inhibitors for cancer therapy: a comprehensive review. Future Med Chem Kulkarni U, Yadav A, Desai P, Thangtinkhum C, Shah D, Nagani A, Shah A, Patel M, Shah U, Patel S, Solanki N, Patel AD. PMID: 42400902 [PubMed - as supplied by publisher]
	Adult cancer survivors' perceptions of immersive virtual reality exercise and its utility during chemotherapy infusion: a concurrent mixed method exploratory study. Support Care Cancer Ferrar K, Lange B, Beltrame T, Buckley ES, Chew KH, Foo JJ, Hollis MK, Kemp E, Koczwara B, Lim P, Mizrahi D, May N, Thomson J, Schumacher J, Hobbs D. PMID: 42400860 [PubMed - indexed for MEDLINE]
	Fusion RNA Profiling in Cancer: Investigating the Etiology of Fusion-Gene-Associated Cancers and Proposing an Approach to Study Connections Between Biological Samples. Methods Mol Biol Xie Z, Yuan H, Li H. PMID: 42400800 [PubMed - indexed for MEDLINE]
	Three-month follow-up of high-dose intravenous iron monotherapy for cancer-related anemia in an ESA-free oncology setting: a real-world cohort study. Int J Clin Oncol Kajiura S, Ishikawa Y, Matsunaga M, Ohotaki I, Shimizu Y, Nakayama Y, Ueda Y, Motoo I, Ando T, Yasuda I, Kato A, Hayashi R. PMID: 42400778 [PubMed - as supplied by publisher]
	Cumulative multidisciplinary team messages and home death after palliative care unit discharge in advanced cancer: a prospective regional implementation cohort study. Int J Clin Oncol Kajiura S, Murakami N, Fujioka S, Tsukada K, Minabe Y, Hayashi R. PMID: 42400777 [PubMed - as supplied by publisher]
	Relationships of serum cabozantinib concentration with tumor response and adverse events in treatment of advanced renal cell carcinoma: observational exploratory prospective study. Int J Clin Oncol Doke Y, Noda S, Kusaba T, Yoshida T, Hira D, Ikeda Y, Kageyama S, Terada T, Morita SY. PMID: 42400775 [PubMed - as supplied by publisher]
	Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study). Clin Transl Oncol Erol C, Zeynelgil E, Hizal M, Dumludag A, Erciyestepe M, Kalaci E, Biter S, Sakalar T, Keskink, Kahraman S, Isik S, Gursoy P, Kutlu Y, Ergun Y, Deliktas I, Yildiz O, Araz M, Akbas S, Can Sanci P, Uygun K, Kalkan Z, Bayram D, Uncu D, Oksuz S, Turan N, Ates O, Bilici A, Kilickap S, Oztop I, Karakaya S, Paydas S, Demirkazik A, Karadurmus N, Sendur MAN. PMID: 42400766 [PubMed - as supplied by publisher]
	Application of metal-based nanoparticles in targeted drug delivery to breast cancer stem cells. Discov Nano Gholizadeh Z, Yousefnia S. PMID: 42400744 [PubMed]
	Identification of exosome-related genes signature based on bioinformatics and machine learning for prognostic prediction in colorectal cancer. Discov Oncol Wang K, Chen T, Chen Y, Zhao J, Fu R, Xu X, Su G, Chen S. PMID: 42400715 [PubMed - as supplied by publisher]
	AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose system. J Med Syst Freudenberg J, Knitza J, Gremke N, Amann N, Deutsch TM, Tauber N, Muras K, Oftring ZS, Engler T, Englisch A, Lukac S, Fabi A, Alves AS, Reinhardt K, Wallwiener M, Kuhlmann M, Bamberger J, Wagner U, Kuhn S, Griewing S. PMID: 42400697 [PubMed - indexed for MEDLINE]
	Tumor-induced immune escape mechanisms and translational immunotherapeutic strategies. Discov Oncol Yousefi M, Farahpour MR, Alizadeh N, Abedian A, Baradaran B. PMID: 42400696 [PubMed - as supplied by publisher]
	Intraoperative technological advances and new frontiers in precision glioma surgery. J Neurooncol Faraj CA, Young CC, Beckham TH, Weinberg JS. PMID: 42400691 [PubMed - indexed for MEDLINE]
	Agreement between the EQ-5D-5L anxiety/depression dimension and GAD-7/PHQ-9 for psychological distress assessment in patients with hematologic malignancies. Qual Life Res Tong F, Zhang Y, Cheng T, Wang S, Chen Y, Qin W, Xu Y. PMID: 42400687 [PubMed - indexed for MEDLINE]
	Exercise trajectories and current exercise and risk of breast cancer: a cohort study of 325,953 women who participated in BreastScreen Norway. Cancer Causes Control Robsahm TE, Støer NC, Bø K, Hofvind S. PMID: 42400682 [PubMed - indexed for MEDLINE]
	Efficacy of different non-pharmacological therapies on cancer-related fatigue in breast cancer patients: a network meta-analysis. Support Care Cancer Li S, Li L, Fu L. PMID: 42400667 [PubMed - indexed for MEDLINE]
	Lessons from the field: culturally grounded approaches to recruiting Chinese American immigrant cancer patients to psycho-oncology trials. Support Care Cancer Lui F, Chen RY, Chang F, Jiang R, Yang K, Zhao C, Gany F, Leng J. PMID: 42400659 [PubMed - indexed for MEDLINE]
	Post-diagnosis physical activity in relation to mortality among gynecological cancer survivors. Cancer Causes Control Hamann A, Benker P, Leitzmann MF, Stein MJ. PMID: 42400650 [PubMed - indexed for MEDLINE]
	GLP-1 receptor agonists at immune checkpoint inhibitor initiation with immune-related and supportive-care outcomes in patients with cancer and overweight or obesity without diabetes: a target trial emulation. Cancer Immunol Immunother Lin YJ, Li PY, Chen SC, Meyerowitz-Katz G, Huang YN, Su PH. PMID: 42400648 [PubMed - as supplied by publisher]
	Macrophage heterogeneity in breast cancer microenvironment and development of a prognostic model: exploring TFF1 as a novel therapeutic target. Cancer Immunol Immunother Chen L, Chen Z, Shi B, Chen L, Zhou G. PMID: 42400645 [PubMed - as supplied by publisher]
	Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation. Cancer Immunol Immunother Jiang Y, Huang H, Feng H, Liu K, Shi Y, Song Z, Cheng X, Ji X, Zhao R. PMID: 42400616 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1952366

Page 1 of 97619



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy